Back to Articles
Safety10 min readFebruary 6, 2025
Who Should Not Take Mounjaro?
A comprehensive guide to Mounjaro contraindications, warnings, and risk factors. Find out if tirzepatide is safe for you.
By Med Consumer Watch Team
Mounjaro (tirzepatide) is highly effective for diabetes and weight loss, but it's not appropriate for everyone. Understanding who should not take Mounjaro is crucial for your safety. This guide covers absolute contraindications, relative contraindications, and important considerations.
Absolute Contraindications
These are situations where Mounjaro should NOT be used:
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Known hypersensitivity to tirzepatide or any product component
- Pregnancy - may cause fetal harm
- Breastfeeding - safety not established
The FDA requires a black box warning about thyroid C-cell tumors on Mounjaro. This is the most serious type of warning.
History of Pancreatitis
Tirzepatide has been associated with pancreatitis cases:
If you have a history of pancreatitis, discuss carefully with your provider. Some may still prescribe with monitoring; others may recommend alternatives.
Symptoms to watch for:
• Severe abdominal pain radiating to back
• Nausea and vomiting
• Fever
Seek immediate care if these occur.
Severe Gastrointestinal Disease
Mounjaro may worsen certain GI conditions:
Use with caution if you have:
• Gastroparesis (delayed stomach emptying)
• Severe GERD
• History of bowel obstruction
• Inflammatory bowel disease
The medication slows gastric emptying, which can worsen these conditions significantly.
Kidney Disease
While Mounjaro doesn't require dose adjustment for kidney function, the GI side effects can cause dehydration and worsen kidney problems.
If you have kidney disease:
• Stay well hydrated
• Report prolonged GI symptoms
• May need more frequent monitoring
• Use with extra caution in advanced kidney disease
Diabetic Retinopathy
Rapid blood sugar improvements can temporarily worsen diabetic eye disease. If you have diabetic retinopathy:
• Have an eye exam before starting
• Inform your ophthalmologist
• Monitor for vision changes
• Report any changes immediately
Drug Interactions
Important medication interactions:
Insulin and sulfonylureas: Doses often need reduction to prevent hypoglycemia.
Oral medications: Slowed gastric emptying may affect absorption of other medications, particularly oral contraceptives.
Discuss all medications with your provider before starting Mounjaro.
Surgical Considerations
If you're having surgery:
Mounjaro should typically be held before procedures requiring anesthesia due to delayed gastric emptying and aspiration risk.
Tell your surgeon and anesthesiologist you take Mounjaro. Follow their guidance on when to stop before surgery.
The Bottom Line
Mounjaro is contraindicated in people with personal or family history of medullary thyroid cancer, MEN 2 syndrome, and known allergy to tirzepatide. Pregnancy and breastfeeding are also contraindications. Many other conditions require careful consideration and may or may not preclude use depending on severity. Always provide complete medical history to your healthcare provider to ensure Mounjaro is safe for you.
Sources & References
- FDA Prescribing Information - Mounjaro
- American Diabetes Association Standards of Care
Medical Disclaimer
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.